LS
HALO icon

Livforsakringsbolaget Skandia’s Halozyme HALO Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.5M Buy
116,100
+11,200
+11% +$790K 0.29% 76
2025
Q4 		$7.06M Hold
104,900
– – 0.27% 79
2025
Q3 		$7.69M Buy
104,900
+2,900
+3% +$193K 0.3% 78
2025
Q2 		$5.31M Buy
102,000
+44,700
+78% +$2.54M 0.23% 94
2025
Q1 		$3.65M Hold
57,300
– – 0.21% 97
2024
Q4 		$2.74M Hold
57,300
– – 0.14% 116
2024
Q3 		$3.28M Buy
57,300
+11,200
+24% +$642K 0.18% 108
2024
Q2 		$2.41M Buy
46,100
+40,800
+770% +$1.79M 0.2% 96
2024
Q1 		$215K Hold
5,300
– – 0.02% 238
2023
Q4 		$196K Buy
+5,300
New +$200K 0.02% 247

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Livforsakringsbolaget Skandia's HALO Position: Q1 2026 in Review

Livforsakringsbolaget Skandia increased its Halozyme (HALO) stake by 11% in Q1 2026, buying an estimated $790K and bringing the position to 116,100 shares worth $7.5M. The position accounts for 0.29% of the portfolio, ranked #76.

Livforsakringsbolaget Skandia first reported a position in HALO in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.69M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Livforsakringsbolaget Skandia held 116,100 shares of Halozyme worth $7.5M as of Q1 2026.
  • Livforsakringsbolaget Skandia bought 11,200 Halozyme shares in Q1 2026, an estimated $790K.
  • Halozyme made up 0.29% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #76 holding.
  • Livforsakringsbolaget Skandia first reported a position in Halozyme in Q4 2023 and has held it in 10 quarters since.
  • Livforsakringsbolaget Skandia's Halozyme position peaked at $7.69M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.